Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease

QR Code

Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease

Enterovirus 71 (EV71) causes childhood hand, foot, and mouth disease and neurological complications, and no vaccines or therapeutic drugs are currently available. Formaldehyde-inactivated whole-virus vaccines derived from EV71 clinical isolates and a mouse-adapted virus (MAV) were tested in a mouse...

Full description

Bibliographic Details
Main Authors:	Ong, Kien Chai, Devi, Shamala, Cardosa, Mary Jane, Wong, Kum Thong
Format:	Article
Language:	English
Published:	American Society for Microbiology 2010
Subjects:	Q Science (General) QR355 Virology R Medicine (General)
Online Access:	http://ir.unimas.my/id/eprint/6978/ http://ir.unimas.my/id/eprint/6978/1/Formaldehyde-Inactivated%20Whole-Virus%20Vaccine%20Protects%20a%20Murine%20Model%20of%20Enterovirus%2071%20Encephalomyelitis%20against%20Disease.pdf

Similar Items

High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1
by: Tan, Cheng Siang, et al.
Published: (2007)

Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)

Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)

Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)

Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)

Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)

Molecular docking of SP40 peptide towards cellular receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)

Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)

Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA
by: Wong, K.T., et al.
Published: (2012)

Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Tan, Le Van, et al.
Published: (2015)

Pluripotent human embryonic stem cell derived neural lineages for in vitro modelling of enterovirus 71 infection and therapy
by: Yap, May Shin *, et al.
Published: (2016)

Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice
by: Lalani, Salima, et al.
Published: (2021)

A decade of sustained selection pressure on two surface sites of the VP1 protein of Enterovirus A71 suggests that immune evasion may be an indirect driver for virulence
by: Roberts, Ryan, et al.
Published: (2019)

Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak.
by: Cardosa, Mary Jane, et al.
Published: (1999)

Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Lim, Hui Xuan *, et al.
Published: (2019)

Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16.
by: Thao, Nguyen Thi Thanh, et al.
Published: (2010)

Novel Multiplex Oligonucleotide-Conjugated Bead Suspension Array for Rapid Identification of Enterovirus 71 Subgenogroups
by: Wu, Y., et al.
Published: (2011)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)

Characterization of plaque variants and the involvement of Quasi-Species in a population of EV-A71
by: Mandary, M. B. *, et al.
Published: (2020)

A monoclonal antibody to ameliorate central nervous system infection and improve survival in a murine model of human Enterovirus-A71 encephalomyelitis
by: Soon, Hao Tan, et al.
Published: (2016)

Validation and utilization of an internally controlled multiplex Real-time RT-PCR assay for simultaneous detection of enteroviruses and enterovirus A71 associated with hand foot and mouth disease
by: Thanh, Tran Tan, et al.
Published: (2015)

RSAD2 and AIM2 modulateCV-A16 and EV-A71 replication in neuronal cells in different ways that may be associated with their 5′ non-translated regions
by: David, Perera
Published: (2017)

Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia
by: Zainulabid, Ummu Afeera, et al.
Published: (2022)

Dengue vaccine design : issues and challenges
by: Cardosa, Mary Jane
Published: (1998)

In Enterovirus 71 Encephalitis With Cardio-Respiratory Compromise, Elevated Interleukin 1β, Interleukin 1 Receptor Antagonist, and Granulocyte Colony-Stimulating Factor Levels Are Markers of Poor Prognosis
by: Griffiths, Michael J., et al.
Published: (2012)

Structural vaccinology for viral vaccine design
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

Development of universal influenza vaccines targeting conserved viral proteins
by: Jazayeri, S. D. *, et al.
Published: (2019)

Recent advances in delivery of veterinary DNA vaccines against avian pathogens
by: Jazayeri, S. D. *, et al.
Published: (2019)

Development of next generation Streptococcus pneumoniae vaccines conferring broad protection
by: Masomian, Malihe *, et al.
Published: (2020)

Viral transmission, neuropathogenesis and therapeutic antibody studies in a murine model of enterovirus 71 encephalomyelitis / Tan Soon Hao
by: Tan, Soon Hao
Published: (2017)

Nano and microparticles as potential oral vaccine carriers and adjuvants against infectious diseases
by: Jazayeri, S. D. *, et al.
Published: (2021)

Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine
by: Lim, Hui Xuan *, et al.
Published: (2021)

Dengue haemorrhagic fever: questions of pathogenesis.
by: Cardosa, Mary Jane
Published: (2000)

Evolutionary dynamics and temporal/geographical correlates of recombination in the human enterovirus echovirus types 9, 11, and 30.
by: Leitch, E. C. McWilliam, et al.
Published: (2010)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

Enhancement of tetravalent immune responses to highly conserved epitopes of a dengue peptide vaccine conjugated to polystyrene nanoparticles
by: Chan, Yanqi, et al.
Published: (2020)